Search

Displaying results 5281 - 5290 of 7706 in total
  1. Drug

    Emicizumab

    go.drugbank.com/drugs/DB13923
    ApprovedInvestigational

    Emicizumab was originated as an improved form of hBS23 and it was approved on November 16, 2017.[A31279, L1016] It was created by Chugai Pharmaceuticals Co.

  2. Drug

    Imiquimod

    go.drugbank.com/drugs/DB00724
    ApprovedInvestigational

    Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas.

    International brands: Li Di, Nan Bo
  3. Drug

    Gestrinone

    go.drugbank.com/drugs/DB11619
    Approved

    However, from 1982 this drug attracted increased interest due to significant therapeutic effects in the treatment endometriosis.

  4. Drug

    Tubercidin

    go.drugbank.com/drugs/DB03172
    Experimental

    An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids

  5. Drug

    Phenothiazine

    go.drugbank.com/drugs/DB11447
    ExperimentalVet approved

    Phenothiazine (PTZ) is an organic thiazine compound.

  6. Drug

    AM365

    go.drugbank.com/drugs/DB06564
    Experimental

    Detiviciclovir (AM365) is an antiviral nucleoside analogue.

  7. Drug

    Aluminium acetoacetate

    go.drugbank.com/drugs/DB13280
    Experimental

    Aluminium acetoacetate is an aluminum containing antacid.

  8. Drug

    Rimazolium

    go.drugbank.com/drugs/DB13289
    Experimental

    Rimazolium is an experimental analgesic drug [A176186].

  9. Drug

    AKI-001

    go.drugbank.com/drugs/DB07266
    Experimental

    AKI-001 is an aurora kinase inhibitor.

  10. Drug

    Diphenyleneiodonium

    go.drugbank.com/drugs/DB17025
    Experimental

    An NADPH oxidase 2 (NOX2) inhibitor.[A252987]